Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

David K ChoiMichelle BeckerMarina IvanovShubha Bhat

Published in: The Annals of pharmacotherapy (2024)

Etrasimod is another possibility in the armamentarium of UC treatment, providing patients with more oral medication options. Prior to treatment initiation, several assessments relating to safety, drug interactions, and pharmacogenomics factors are advised.

Keyphrases

healthcare
emergency department
combination therapy
adverse drug
replacement therapy
binding protein
drug induced